Results 171 to 180 of about 167,095 (266)

Trial Protocol: A Randomised, Controlled Cross‐Over Trial Evaluating the Digital Sleep Revolution Diagnostic‐Therapeutic Pathway for Obstructive Sleep Apnoea

Journal of Sleep Research, EarlyView.
ABSTRACT Obstructive sleep apnoea (OSA) is common, but current diagnostic pathways rely on single‐night assessment and the apnoea–hypopnoea index. Both are limited for assessment of variability and linking only weakly to symptoms, comorbidity and treatment response.
Ludger Grote, Erna Sif Arnardottir, Özen K. Basoglu, Maria R. Bonsignore, Zoran Dogas, Marta Drummond, Francesco Fanfulla, Haralampos Gouveris, Carolina Lombardi, Stefan Mihaicuta, Athanasia Pataka, Thomas Penzel, Winfried Randerath, Silke Ryan, Tarja Saaresranta, Sophia Schiza, Pawel Sliwinski, Richard Staats, Dries Testelmans, Paschalis Steiropoulos, Georgia Trakada, Johan Verbraecken, Sebastien Bailly, Anna Sigridur Islind, Timo Leppänen, Dirk Pevernagie, Ding Zou, Dimitri Ferretti, Jan Hedner, the Sleep Revolution Collaborators   +29 more
wiley   +1 more source

Patient-Reported Health Status and Clinical Outcomes After CTO-PCI Versus Optimal Medical Therapy: A 12-Month Retrospective Observational Cohort Analysis. [PDF]

J Clin Med
Doktorova V, Goranov G, Nikolov P, Marinov M.   +3 more
europepmc   +1 more source

Application of machine learning algorithms to predict heat-sensitive angina (HSA) attacks: a multicentric observational cohort study. [PDF]

Front Digit Health
Wang J, Zhou C, Zhao Y, Hu J.
europepmc   +1 more source

Facial Cellulitis Mimicking Ludwig's Angina in a Patient with Chronic Myelogenous Leukemia on Dasatinib Therapy. [PDF]

Infect Dis Rep
Liang N, DeTemple J, Potts CE, Alizai U, Meadows C.   +4 more
europepmc   +1 more source

Low Weight Loss Response to Incretin Analogs: A Systematic Review

Obesity Reviews, EarlyView.
ABSTRACT The development of GLP‐1 and GIP analogs has been a significant breakthrough in type 2 diabetes and obesity pharmacotherapy. However, individual responses to these medications can vary widely. This systematic review examines factors associated with low or no weight loss response to GLP‐1 and GIP analogs. Key predictors of poor response include
Pamela S. Gaskin, Peter S. Chami
wiley   +1 more source

Application of predicting risk of cardiovascular disease events equations on postoperative major adverse cardiac and cerebral events for patients undergoing thoracic surgery. [PDF]

Front Cardiovasc Med
Fan WQ, Wang S, Zhu EY, Yu CY, Liu YK, Li H, Liu KX, Liu HM.   +7 more
europepmc   +1 more source

Established and Emerging Biomarkers to Characterize Persons at Risk for Obesity—Paving the Way for Targeted Clinical Intervention Trials—A Comprehensive Position Paper

Obesity Reviews, EarlyView.
ABSTRACT Despite all efforts, obesity remains a major health concern worldwide, with continuously increasing rates, affecting approx. 14% of the total world population, being as high as 43% in some countries. As obesity is related to numerous comorbidities, including type 2 diabetes, cardiovascular diseases, and some types of cancer, the consequences ...
Farhad Vahid, Victoria Stopa, Laurent Malisoux, Yvan Devaux, Elsa Lamy, Fernando Capela e Silva, Sarah Forberger, Tiziana de Magistris, Antoni Sureda, Margalida Monserrat‐Mesquida, Maria Pérez‐Jiménez, Rajini Nagrani, Maria Giovanna Onorati, Michele Filippo Fontefrancesco, Jonathan Turner, Mahesh S. Desai, Josep Tur, Cristina Bouzas, Gino Gabriel Bonetti, Oliver Riedel, Gitte Ravn‐Haren, Rikke Andersen, Torsten Bohn   +22 more
wiley   +1 more source

Cardiovascular Outcomes of GLP‐1–Based Medicines Among People With Overweight and Obesity: An Umbrella Review of Meta‐Analyses of Randomized Controlled Trials

Obesity Reviews, EarlyView.
ABSTRACT Introduction Cardiovascular (CV) outcomes of Glucagon‐like peptide‐1 (GLP‐1)–based medicines among people with overweight and obese (OW/OB) population have been investigated by meta‐analyses of randomized controlled trials (RCTs), but an overall summary is lacking.
Muhammed Rashid, E. Lyn Lee, Sajesh K. Veettil, Teerapon Dhippayom, Alice Y. Y. Cheng, Juliana Simonetti, Nathorn Chaiyakunapruk   +6 more
wiley   +1 more source

Association between coronary vasomotor dysfunction and autoimmune disease in patients undergoing invasive coronary function testing. [PDF]

Int J Cardiol Heart Vasc
Latif N, Zeng Y, Kostantinis S, Furman M, Feher A, Hinchcliff M, Cigarroa N, Tong G, Kunnirickal SJ, Odanovic N, Shah SM.   +10 more
europepmc   +1 more source